Has the Amazon Prime of Cancer Genomic Profiling Arrived?

Posted by Pavankumar Anne on Dec 12, 2019 9:31:04 AM

Jim Adelizzi co-wrote this blog post with Pavankumar Anne.

The excitement behind precision medicine in oncology is impossible to ignore. Genomic profiling has enabled the greatest growth in precision medicine in oncology, and today there are 80-plus FDA-approved treatment options indicated for specific genetic markers. Innovations in next-generation sequencing (NGS) technology have further enabled advances in genomic profiling by increasing the speed, accuracy and affordability of sequencing. With this innovation comes a variety of options for testing:


>
Read More